Women at Higher Risk of Serious Adverse Events From Cancer Therapy Women at Higher Risk of Serious Adverse Events From Cancer Therapy
Women are more likely to have serious adverse events when treated with chemotherapy and targeted agents, and especially so with immunotherapy.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Health | Hematology | Immunotherapy | Women